Edition:
United Kingdom

Microbot Medical Inc (MBOT.OQ)

MBOT.OQ on NASDAQ Stock Exchange Capital Market

0.80USD
8:40pm BST
Change (% chg)

$-0.00 (-0.44%)
Prev Close
$0.80
Open
$0.80
Day's High
$0.81
Day's Low
$0.80
Volume
25,789
Avg. Vol
38,775
52-wk High
$1.75
52-wk Low
$0.58

Latest Key Developments (Source: Significant Developments)

Microbot Medical Expects To Reach Development Milestones For Self Cleaning Shunt In Late 2018 Or Early 2019
Thursday, 12 Apr 2018 

April 12 (Reuters) - Microbot Medical Inc ::BELIEVES WILL REACH ANTICIPATED DEVELOPMENT MILESTONES FOR SELF-CLEANING SHUNT, SUBMISSION WITH FDA IN LATE 2018/EARLY 2019.  Full Article

Microbot Medical Says ‍U.S. Patent And Trademark Office Issued A Notice Of Allowance Covering Company's Tipcat Technology Platform​
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Microbot Medical Inc ::MICROBOT MEDICAL INC - ‍U.S. PATENT AND TRADEMARK OFFICE ISSUED A NOTICE OF ALLOWANCE COVERING COMPANY'S TIPCAT TECHNOLOGY PLATFORM​.  Full Article

Microbot Medical files for mixed shelf of up to $75 mln
Friday, 31 Mar 2017 

Microbot Medical Inc :Files for mixed shelf of up to $75.0 million - sec filing.  Full Article

Stemcells says respective boards of co and Microbot approved merger agreement
Monday, 15 Aug 2016 

Stemcells Inc : Respective boards of directors of stemcells and microbot have approved merger agreement - sec filing . Following consummation of merger, former stockholders of microbot and certain advisors with respect to merger expected to own 95% of combined co . Following consummation of merger, current stockholders of microbot expected to own 5% of combined co . On august 15, 2016, co entered into an agreement and plan of merger and reorganization with microbot medical ltd . Co will seek to amend its certificate of incorporation to effect a reverse stock split of company's common stock, if necessary . Will seek to amend its certificate of incorporation to change name of co to 'microbot medical inc.' or another name designated by microbot .Merger agreement provides that board of directors of company will be designated by microbot.  Full Article

Stemcells says files for non-timely 10-q with U.S. SEC - SEC Filing
Tuesday, 9 Aug 2016 

Stemcells Inc : Says files for non-timely 10-q with u.s. SEC - SEC Filing . Says in May 2016, decided to terminate its Phase II pathway study in spinal cord injury following an in-depth review . As part of wind down of company’s operations, it conducted a reduction of work force impacting all of its remaining full-time employees . Reduction consisting of approximately 50 employees, as of August 1, 2016 .Expects to file its form 10-q within the 5-day extension period afforded by rule 12b-25.  Full Article

BRIEF-Microbot Medical Exercises Option To Buy Novel Technology From Cardiosert

* MICROBOT MEDICAL EXERCISES OPTION TO ACQUIRE NOVEL TECHNOLOGY FROM CARDIOSERT LTD. Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)